684 related articles for article (PubMed ID: 26229406)
1. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status.
Zheng YZ; Zhao W; Hu Y; Ding-Lin XX; Wen J; Yang H; Liu QW; Luo KJ; Huang QY; Chen JY; Fu JH
World J Gastroenterol; 2015 Jul; 21(28):8644-52. PubMed ID: 26229406
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lin D; Ye T; Ma L; Shao L; Song Z; Jiang S; Xiang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):990-994. PubMed ID: 27680065
[TBL] [Abstract][Full Text] [Related]
3. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
5. The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis?
Xu QR; Zhuge XP; Zhang HL; Ping YM; Chen LQ
World J Surg; 2011 Jun; 35(6):1303-10. PubMed ID: 21452071
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of perigastric lymph nodes metastases on survival in patients with thoracic esophageal cancer.
Wu ZY; Yu JC; Xu LY; Shen JH; Wu JZ; Wang SH; Fu JH; Fan YH; Yang BN; Shen ZY; Huang Q; Li EM
Dis Esophagus; 2010 Jan; 23(1):40-5. PubMed ID: 19392853
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
[TBL] [Abstract][Full Text] [Related]
8. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
9. Pre- and post-therapy nodal status equally affects survival of patients with oesophageal squamous cell carcinoma receiving preoperative chemoradiation.
Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Mori M; Doki Y
Oncol Rep; 2010 May; 23(5):1331-7. PubMed ID: 20372848
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection.
Hsu PK; Huang CS; Wang BY; Wu YC; Chou TY; Hsu WH
Ann Thorac Surg; 2013 Sep; 96(3):995-1001. PubMed ID: 23866797
[TBL] [Abstract][Full Text] [Related]
11. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
12. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
[TBL] [Abstract][Full Text] [Related]
13. Right versus left transthoracic approach for lymph node-negative esophageal squamous cell carcinoma.
Ma Q; Liu W; Long H; Rong T; Zhang L; Lin Y; Ma G
J Cardiothorac Surg; 2015 Sep; 10():123. PubMed ID: 26384482
[TBL] [Abstract][Full Text] [Related]
14. Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery.
Ye B; Zhong CX; Yang Y; Fang WT; Mao T; Ji CY; Li ZG
World J Gastroenterol; 2016 May; 22(19):4750-6. PubMed ID: 27217706
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma].
Yang X; Zhan C; Sun F; Chen L; Shi M; Jiang W; Wang Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):979-984. PubMed ID: 27680063
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
17. Extent of lymph node removal during esophageal cancer surgery and survival.
van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
[TBL] [Abstract][Full Text] [Related]
18. Curative effect comparison between Ivor-Lewis esophagectomy and left transthoracic esophagectomy in treatment of middle thoracic esophagus carcinoma.
Song L; Liu Y; Wang Z; Ren WG; Liu XY
Hepatogastroenterology; 2012 May; 59(115):738-41. PubMed ID: 22024231
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Kotoh T; Shibakita M; Ohno S; Masunaga R; Kubota H; Kohno H; Nagasue N
J Surg Oncol; 1999 Oct; 72(2):88-93. PubMed ID: 10518105
[TBL] [Abstract][Full Text] [Related]
20. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
Sun ZG; Wang Z
Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
